Bleichroeder’s Immix Biopharma IMMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10.4M Hold
1,000,000
– – 1.02% 38
2026
Q2
$10.3M Hold
1,000,000
– – 1.84% 10
2026
Q1
$9.11M Hold
1,000,000
– – 1.57% 12
2025
Q4
$5.23M Buy
1,000,000
+150,000
+18% +$617K 0.92% 14
2025
Q3
$1.78M Hold
850,000
– – 0.35% 29
2025
Q2
$1.76M Hold
850,000
– – 0.43% 24
2025
Q1
$1.43M Hold
850,000
– – 0.38% 25
2024
Q4
$1.87M Hold
850,000
– – 0.47% 22
2024
Q3
$1.27M Hold
850,000
– – 0.34% 29
2024
Q2
$1.68M Hold
850,000
– – 0.5% 23
2024
Q1
$2.61M Buy
+850,000
New +$3.29M 0.65% 21

Other funds holding IMMX

Bleichroeder's IMMX Position: Q3 2026 in Review

Bleichroeder held its Immix Biopharma (IMMX) position steady in Q3 2026 at 1,000,000 shares worth $10.4M. The position accounts for 1.02% of the portfolio, ranked #38.

Bleichroeder first reported a position in IMMX in Q1 2024 and has held it in 11 quarters since. 87 funds tracked by Wall St. Rank hold IMMX as of Q3 2026.

  • Bleichroeder held 1,000,000 shares of Immix Biopharma worth $10.4M as of Q3 2026.
  • Bleichroeder left its Immix Biopharma share count unchanged in Q3 2026.
  • Immix Biopharma made up 1.02% of Bleichroeder's portfolio in Q3 2026, its #38 holding.
  • Bleichroeder first reported a position in Immix Biopharma in Q1 2024 and has held it in 11 quarters since.
  • 87 funds tracked by Wall St. Rank held Immix Biopharma as of Q3 2026.

Based on Bleichroeder's 13F filing for Q3 2026, filed 13 Nov 2026.